Showing results (261-270 of 382) with videos related to
Sort By:
Pageof 39
Urologic Oncology|November 26, 2022
Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?Muhannad Alsyouf, Seyedeh-Sanam Ladi-Seyedian, Badrinath Konety, et al.Nature Immunology|February 7, 2012
The composition and signaling of the IL-35 receptor are unconventionalLauren W Collison, Greg M Delgoffe, Clifford S Guy, et al.Cancer Research|August 21, 2020
A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic CancerTamas A Gonda, Jarwei Fang, Martha Salas, et al.The Prostate|August 12, 2020
Optimizing the management of castration-resistant prostate cancer patients: A practical guide for cliniciansNeal D Shore, Charles G Drake, Daniel W Lin, et al.The Journal of Clinical Investigation|October 13, 2007
LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systemsJoseph F Grosso, Cristin C Kelleher, Timothy J Harris, et al.Seminars in Oncology|November 24, 2019
A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamideHarshraj Leuva, Keith Sigel, Mengxi Zhou, et al.Prostate Cancer and Prostatic Diseases|December 6, 2017
Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP modelYing-Chun Shen, Ali Ghasemzadeh, Christina M Kochel, et al.Science (New York, N.Y.)|August 22, 2009
Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cellsFan Pan, Hong Yu, Eric V Dang, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunityTimothy J Harris, Joseph F Grosso, Hung-Rong Yen, et al.Molecular Immunology|March 16, 2010
A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cellsDerese Getnet, Joseph F Grosso, Monica V Goldberg, et al.Pageof 39